Ross J. Baldessarini

Ross J. Baldessarini (born 1937, Western Massachusetts),[1] a psychopharmacologist, is the Director, International Consortium for Bipolar & Psychotic Disorders Research at McLean Hospital and Professor of Psychiatry (Neuroscience) at Harvard Medical School.[2]

Education

Publications

Books

Chemotherapy in Psychiatry: Pharmacologic Basis of Treatments for Major Mental Illness

Selected Journal Articles

Selected Publications Vázquez GH, Tondo L, Undurraga J, Baldessarini RJ. Overview of antidepressant treatment of bipolar depression. International Journal of Neuropsychopharmacology 2013;16(7):1673-1685.

Yildiz A, Vieta E, Nikodem M, Correll CU, Baldessarini RJ. A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine 2014;1–19.

Schalkwijk S, Undurraga J, Tondo L, Baldessarini RJ. Declining efficacy in controlled trials of antidepressants: effects of placebo dropout. International Journal of Neuropsychopharmacology 2014;17(8):1343-1352.

References
  1. "Ross J. Baldessarini, M.D., M.A. (hon.), D.Sc. (hon.), DLFAPA, FACP, FACNP, FCINP". International Network for the History of Neuropsychopharmacology. Retrieved 25 June 2021.
  2. "Ross J. Baldessarini, MD". McLean Hospital. Retrieved 25 June 2021.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.